Published Medical “Sweet-P”- Cancer Treatment Treating GRβ-related diseases including bladder cancer, prostate cancer, lung cancer, leukaemia, glioblastoma, liver cancer, breast cancer, lupus, and asthma. By Anne Izzi
Published Healthcare & Pharmaceuticals ER+ Breast Cancer Prognostic Glucocorticoid Receptor promoter methylation has both positive and negative prognostic value for ER+ breast cancer patients and may be able to predict treatment response By Queen’s University
Do you have an innovative technology, product or service? Add your solution to the world’s most advanced open innovation platform and get seen by global corporations seeking new solutions – all free of charge.
